Stocks›Healthcare›TECH

TECH

BIO-TECHNE Corp

NasdaqResearch view

Healthcare · Biological Products, (No Diagnostic Substances) · Large-cap · SEC EDGAR FY 2026-06-30

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2026-06-30

SectorHealthcare

Market Cap$11.3B

Enterprise Value$11.1B

Income$181.9M

Sales$1.2B

Book/sh$13.44

Cash/sh$1.69

Dividend TTM$0.32

Payout27%

Employees—

IPO—

Quick Ratio3.35

Current Ratio4.55

Debt/Eq0.01

EPS (ttm)$1.16

EPS this Y152.2%

EPS past 3/5Y-13.0%

Sales past 3/5Y2.2%

EPS Y/Y TTM152.2%

Sales Y/Y TTM-0.4%

Shs Outstand156.82M

ROA7.0%

ROE8.6%

ROIC10.3%

Gross Margin65.8%

Oper. Margin20.7%

Profit Margin15.0%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

$1.1B

2022

$1.1B

2023

$1.2B

2024

$1.2B

2025

$1.2B

2026

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

USD	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$1.1B	$1.1B	$1.2B	$1.2B	$1.2B
Gross Profit	$756.5M	$769.8M	$769.7M	$790.3M	$799.1M
Operating Income	$296.6M	$298.9M	$206.7M	$102.3M	$251.9M
Net Income	$272.1M	$285.3M	$168.1M	$73.4M	$181.9M
Diluted EPS	$1.66	$1.76	$1.05	$0.46	$1.16
Operating Cash Flow	$325.3M	$254.4M	$299.0M	$287.6M	$292.1M
Free Cash Flow	$280.4M	$216.1M	$236.1M	$256.6M	$263.2M